Global Metabolic Disorder Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Disease;

Lysosomal Storage Diseases - Gaucher’s Disease, Metachromatic leukodystrophy, Hurler - Scheie Disease, Sanfilipo A disease and Other, Diabetes, Obesity, Inherited Metabolic Disorders and Hypercholesterolemia.

Segmented by Therapy Type;

Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule-Based Therapy, Substrate Reduction Therapy, Gene Therapy and Drug Therapy.

Segmented by Administration Route;

Oral , Parenteral and Other.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn651404480 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Metabolic Disorder Therapeutics Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 62.7
2021 71.9
2022 81.6
2023 90.9
2024 91.1
2025 107.3
2026 123.8
2027 144.8
2028 149.1
2029 163.6
2030 195.9

In the year 2023, the Global Metabolic Disorder Therapeutics Market was valued at USD 90,539.04 million. The size of this market is expected to increase to USD 146,339.71 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Disease
    2. Market Snapshot, By Therapy Type
    3. Market Snapshot, By Administration Route
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Metabolic Disorder Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of metabolic disorders
        2. Collaborations between manufacturers and research facilities
        3. Government initiatives
      2. Restraints
        1. Expensive rare disease therapies
        2. Ambiguous regulatory policies
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Metabolic Disorder Therapeutics Market, By Disease, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Lysosomal Storage Diseases
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Gaucher’s Disease
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Metachromatic leukodystrophy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Hurler - Scheie Disease
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. Sanfilipo A disease
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. Other
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Diabetes
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Obesity
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Inherited Metabolic Disorders
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Hypercholesterolemia
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Metabolic Disorder Therapeutics Market, By Therapy Type, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Enzyme Replacement Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Cellular Transplantation
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Small Molecule-Based Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Substrate Reduction Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Gene Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Drug Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Metabolic Disorder Therapeutics Market, By Administration Route, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Parenteral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Other
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Global Metabolic Disorder Therapeutics Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Administration Route, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Novo Nordisk
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Shire Plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Merck KgaA
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. AstraZeneca
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. AbbVie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Actelion Pharmaceuticals Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Amgen Inc.,
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Biocon
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      11. BioMarin
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      12. Boehringer Ingelheim
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      13. Bristol-Myers Squibb
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      14. Cipla Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      15. CymaBay Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Metal Implants And Medical Alloys
Global Metal Implants And Medical Alloys Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Metal Implants And Medical Alloys Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Metastases Spinal Tumor
Global Metastases Spinal Tumor Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Metastases Spinal Tumor Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Metabolomics Services
Global Metabolomics Services Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Metabolomics Services Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Metagenomic Sequencing
Global Metagenomic Sequencing Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Metagenomic Sequencing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...